[1]
Li, G. et al. 2025. An updated review on the utility of hematopoietic stem cell transplant in the treatment of refractory myasthenia gravis. RRNMF Neuromuscular Journal. 6, 1 (Mar. 2025). DOI:https://doi.org/10.17161/rrnmf.v6i1.22987.